Tdap vaccine appears safe in pregnant women

Organisation: Position: Deadline Date: Location:

New research [b]Baylor College of Medicine, Houston[/b], suggests that vaccinating pregnant women during their third trimester to prevent tetanus, diphtheria and pertussis in their future offspring appears to be safe for both mother and child, reports [s]Medicinenet[/s]. The new preliminary study explored the safety of the ‘Tdap’ vaccine when offered before birth. The investigation was prompted by the particular threat to infants posed by pertussis – commonly known as whooping cough – a highly contagious and sometimes deadly disease. Although the disease is preventable if vaccinated against, current recommendations advise that the ‘DTaP vaccine – a different form of the vaccine used to prevent the same conditions – be offered only to infants at the ages of 2 months, 4 months and 6 months. This leaves open a potential window of risk between the time of birth and the first dose of DTaP, in which the newborn infant is not protected.

Full Medicinenet report
Jama abstract

Receive Medical Brief's free weekly e-newsletter

Related Posts

Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.